Lv3
338 积分 2022-10-24 加入
Ten-Year Outcomes after CAR T-Cell Therapy for B-Cell Lymphomas
2个月前
已完结
Sabatolimab plus hypomethylating agents in previously untreated patients with higher-risk myelodysplastic syndromes (STIMULUS-MDS1): a randomised, double-blind, placebo-controlled, phase 2 trial
2个月前
已完结
ECM1 attenuates hepatic fibrosis by interfering with mediators of latent TGF-β1 activation
9个月前
已完结
The hallmarks of cancer immune evasion
1年前
已完结
皖公网安备34019202002308
